Skip to main content

Advertisement

Log in

PEXIVAS – Der Todesstoß für den Plasmaaustausch bei ANCA-assoziierter Vaskulitis?

PEXIVAS—The kiss of death for plasma exchange in ANCA-associated vasculitis?

  • Klinische Studien kurzgefasst
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Schirmer JH, Aries PM, de Groot K, Hellmich B, Holle JU, Kneitz C et al (2017) S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden. Z Rheumatol 76(Suppl 3):77–104

    Article  PubMed  Google Scholar 

  2. Jayne DRW, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18(7):2180–2188

    Article  CAS  PubMed  Google Scholar 

  3. Walsh M, Casian A, Flossmann O, Westman K, Höglund P, Pusey C et al (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 84(2):397–402

    Article  CAS  PubMed  Google Scholar 

  4. Hellmich B, Löffler C (2019) What are the indications for rescue procedures? Systemic rheumatic diseases in the intensive care unit. Z Rheumatol 78(10):955–966

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Johnson JP, Moore J, Austin HAI, Balow JE, Antonovych TT, Wilson CB (1985) Therapy of anti glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 64(4):219–227

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Löffler.

Ethics declarations

Interessenkonflikt

C. Löffler und B. Hellmich geben an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

C. Fiehn, Baden Baden

B. Hellmich, Kirchheim-Teck

I. Kötter, Hamburg

K. Krüger, München

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Löffler, C., Hellmich, B. PEXIVAS – Der Todesstoß für den Plasmaaustausch bei ANCA-assoziierter Vaskulitis?. Z Rheumatol 79, 910–911 (2020). https://doi.org/10.1007/s00393-020-00895-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-020-00895-z

Navigation